下斜肌肉毒毒素注射治疗V型斜视与原发位垂直斜视
一项回顾性病例系列研究评估了下斜肌注射A型肉毒毒素(BTX)治疗V型斜视和原发位垂直斜视的效果。研究纳入2010至2020年波士顿儿童医院20例患者,结果显示V型斜视短期显著改善但长期无统计学意义,原发位垂直斜视仅短期改善,长期无获益。
要点
- 下斜肌BTX注射可短期改善V型斜视,但长期无统计学意义。
- 原发位垂直斜视仅短期缓解,无长期获益预期。
- 下斜肌注射未见并发症。
核心结论
- 下斜肌BTX注射可作为V型斜视管理的辅助手段。
- 原发位垂直斜视干预可能仅有助于短期缓解,无长期获益预期。
研究设计与样本
- 回顾性病例系列,单中心(波士顿儿童医院眼科),纳入2010至2020年所有接受下斜肌BTX(onabotulinumtoxinA)注射的患者。
主要发现
- 共20例患者,中位年龄4.5岁(范围1-69岁),注射31条下斜肌,中位剂量5.0单位(范围3.0-7.0单位)。
- V型斜视中位幅度从术前10棱镜度(PD)变为短期0 PD(P = .006)和长期3.5 PD(P = .34)。
- 原发位垂直斜视中位幅度从术前8.5 PD变为短期1.5 PD(P = .01)和长期8 PD(P = .87)。
- 下斜肌过动分级在短期(P < .001)和长期(P = .007)均显著改善。
- 无与下斜肌注射相关的并发症。
关键数值与推荐
- V型斜视短期P = .006,长期P = .34;原发位垂直斜视短期P = .01,长期P = .87。
- 下斜肌过动分级短期P < .001,长期P = .007。
临床怎么用
- 可考虑将下斜肌BTX注射作为V型斜视的辅助治疗。
- 对原发位垂直斜视,应向患者说明仅可能短期缓解,无长期获益预期。
局限性
- 回顾性病例系列,样本量小(20例),无对照组。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To evaluate outcomes of botulinum toxin (BTX) injection of the inferior oblique (IO) muscle. DESIGN: Retrospective case series. METHODS: Setting: Single center, ophthalmology department at Boston Children's Hospital. STUDY POPULATION: All patients treated with IO muscle injection of BTX (onabotulinumtoxinA) between 2010 and 2020. OBSERVATION PROCEDURE: Sensorimotor evaluations at short-term (<2 months), medium-term (2-4 months), and long-term (≥4 months) intervals. OUTCOME MEASURE: Primary outcomes included median improvement in V-pattern strabismus and primary position hypertropia. Secondary outcomes included IO muscle overaction. Wilcoxon signed-rank tests were performed to identify differences before and after injection. RESULTS: Record review identified 20 patients with a median age of 4.5 (range, 1-69) years. Median BTX dose injected (31 IO muscles) was 5.0 (range, 3.0-7.0) units. Indications included V-pattern strabismus (N = 8), hypertropia (N = 7), or both (N = 5). Median long-term interval was 6.4 (range, 4.1-26.6) months. Injections were concurrent with treatment of horizontal strabismus in all but 3 cases. Median V-pattern magnitude changed from 10 prism diopters (PD) preoperatively to 0 PD short-term (P = .006) and 3.5 PD long-term (P = .34). Median hypertropia changed from 8.5 PD preoperatively to 1.5 PD short-term (P = .01) and 8 PD long-term (P = .87). Median IO muscle overaction grade improved significantly at short-term (P < .001) and long-term (P = .007) intervals. There were no complications associated with the IO muscle injections. CONCLUSIONS: BTX injection of the IO muscles can be a useful adjunct to the management of V-pattern strabismus. Intervention for primary position hypertropia may be helpful for short-term relief with no expectation of long-term benefit.
引用
- Oke I, Elhusseiny AM, Shah AS, et al. Botulinum Toxin Injection of the Inferior Oblique Muscles for V-Pattern Strabismus and Primary Position Hypertropia. Am J Ophthalmol. 2021. PMID: 34283987. doi:10.1016/j.ajo.2021.07.003
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。